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Abstract
The hematopoietic inductive microenvironment (HIM) is where hematopoietic stem/progenitor cells grow and develop.
Hematopoietic stromal cells were the key components of the HIM. In our previous study, we had successfully cultured and
isolated human cord blood–derived stromal cells (HUCBSCs) and demonstrated that they could secret hemopoietic growth
factors such as GM-CSF, TPO, and SCF. However, it is still controversial whether HUCBSCs can be used for reconstruction of
HIM. In this study, we first established a co-culture system of HUCBSCs and cord blood CD34
+ cells and then determined
that using HUCBSCs as the adherent layer had significantly more newly formed colonies of each hematopoietic lineage than
the control group, indicating that HUCBSCs had the ability to promote the proliferation of hematopoietic stem cells/
progenitor cells. Furthermore, the number of colonies was significantly higher in vascular cell adhesion molecule-1 (VCAM-
1)-modified HUCBSCs, suggesting that the ability of HUCBSCs in promoting the proliferation of hematopoietic stem cells/
progenitor cells was further enhanced after having been modified with VCAM-1. Next, HUCBSCs were infused into a
radiation-damaged animal model, in which the recovery of hematopoiesis was observed. The results demonstrate that the
transplanted HUCBSCs were ‘‘homed in’’ to bone marrow and played roles in promoting the recovery of irradiation-induced
hematopoietic damage and repairing HIM. Compared with the control group, the HUCBSC group had significantly superior
effectiveness in terms of the recovery time for hemogram and myelogram, CFU-F, CFU-GM, BFU-E, and CFU-Meg. Such
differences were even more significant in VCAM-1-modified HUCBSCs group. We suggest that HUCBSCs are able to restore
the functions of HIM and promote the recovery of radiation-induced hematopoietic damage. VCAM-1 plays an important
role in supporting the repair of HIM damage.
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Introduction
The hematopoietic inductive microenvironment (HIM) is where
hematopoietic stem/progenitor cells (HSCs/HPCs) grow and
develop [1]. Hematopoietic stromal cells, one of the key
components of the HIM, primarily exist in tissues and organs
such as bone marrow, spleen, and thymus [2]. Through direct
contact with HSCs/HPCs and secretion of pluripotent hemato-
poietic growth factors (HGFs) and extracellular matrix (ECM),
hematopoietic stromal cells not only are associated with the
homing, proliferation, differentiation, and self-renewal of HSCs/
HPCs but also play important roles in the occurrence, progression,
and prognosis of some hematologic diseases [3,4].
After stem cell transplantation, the ability of adherent bone
marrow stromal cells of patients pre-treated with radiotherapy and
chemotherapy have reduced ability to support the growth of
HSCs/HPCs [5]. Some biological factors, such as cytomegalovi-
rus, hepatitis B virus, and human immunodeficiency virus as well
as physical and chemical factors, such as radiation and
chemotherapeutic drugs, can cause hematopoietic dysfunction
through the damage of stromal cells. In some disease states such as
aplastic anemia, acute and chronic myeloid leukemia, and
myelodysplastic syndrome, the abnormal hematopoietic function
is associated with dysfunction of HSCs/HPCs as well as the
number of stromal cells or dysfunction of stromal cells in the bone
marrow HIM [5,6,7,8,9].
The hematopoietic dysfunction caused by damage of stromal
cells in the HIM is longer-lasting than damage of parenchymal
cells and, in fact, can be irreversible [10]. Therefore, repair or
reconstruction of normal HIM function has become clinically
challenging.
Autologous infusion of cultured and expanded bone marrow
stromal cells is an effective ancillary method for repairing damaged
hematopoietic function in experimental and clinical studies. The
extensive use of hematopoietic stromal cells in the clinic is limited
due to the dysfunction of the microenvironment in autologous
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disorders or due to immune-related problems such as graft-
versus-host disease (GVHD) from allogeneic stromal cell implan-
tation; moreover, the clinical values of fetal liver, thymus, and
other tissue-derived stromal cells are hampered by ethical
considerations. Therefore,searching for new sources of hemato-
poietic stromal cells that are convenient, healthy, and universally
applicable is a topic of intense interest. HSCs/HPCs in umbilical
cord blood are more primitive and have the advantages of a higher
proliferation rate and more rapid hematopoietic reconstruction
than those in bone marrow and peripheral blood. In addition,
GVHD after cord blood transplantation usually is mild, and the
graft-versus-leukemia effect will not be an issue; therefore, even
HLA-incompatible cord blood can be successfully transplanted
without ethical concerns [11]. Hematopoietic stromal cells mainly
exist in bone marrow; however, it is still controversial whether
cord blood contains stromal cells that can be used for
reconstruction of HIM. Our team had cultured adherent cells
from cord blood using Dexter’s culture system. After identification
by their surface markers, these cells have the biological
characteristics of stromal cells and secreted HGFs; therefore, they
were named human cord blood–derived stromal cells (HUCBSCs)
[12]. In subsequent studies, our team further discovered that
HUCBSCs not only promoted the reconstruction of erythroid and
other hematopoietic lineages ex vivo, but interestingly, they also had
a stronger ability to promote megakaryocyte proliferation than
bone marrow stromal cells [13,14]. In addition, they inhibited the
occurrence of GVHD to some extent [15,16]. The above results
led us to believe that HUCBSCs might be a promising new source
of hematopoietic stromal cells.
During the process of HSC transplantation, the homing of
stem/progenitor cells is a major factor determining the success of
transplantation. The molecular basis of the homing of HSCs/
HPSs is specifically mediated by corresponding receptors and
ligands of cell adhesion molecules (CAMs) expressed by hemato-
poietic parenchymal and stromal cells. The specific interaction
between a4b1 integrin expressed by parenchymal cells and
vascular cell adhesion molecule-1 (VCAM-1), an immunoglobulin
(Ig) superfamily member expressed by bone marrow stromal cells,
plays a key role in the adhesion of stem cells to the bone marrow
stroma. Anti-a4b1 or anti-VCAM-1 monoclonal antibodies can
block the adhesion of HSCs/HPCs to the adherent layer of bone
marrow stromal cells [17]. The level of expression of VCAM-1 in
hematopoietic stromal cells can affect the homing of HSCs, thus
further affecting the process of hematopoietic reconstruction. Our
previous studies showed that VCAM-1 expression in HUCBSCs
was lower than that in bone marrow stromal cells, which might
affect its ability to regulate hematopoiesis [18] To investigate the
effect of the VCAM-1 gene on the ability of HUCBSCs in
regulating hematopoiesis, a VCAM-1 high-expressing vector had
been constructed using recombinant DNA technology and
successfully transfected into HUCBSCs [19], which provided an
effective tool and vector to study the function of VCAM-1–
modified HUCBSCs in the regulation of hematopoiesis.
In this study, we first established a co-culture system of VCAM-
1–modified HUCBSCs and cord blood CD34
+ cells and then
determined that VCAM-1–modified HUCBSCs had a stronger
ability to support hematopoiesis in vitro. Next, VCAM-1–modified
HUCBSCs wereinfused into a radiation-damaged animalmodel, in
which the recovery of hematopoiesis was observed. The results
demonstrate that transplantation of VCAM-1–modified HUCBSCs
could repair functional damage to HIMand promote recovery from
hematopoietic damage.
Materials and Methods
Source of cord blood
Twenty samples of cord blood weretaken from umbilical cords of
full-term normal-delivery babies delivered by healthy mothers at
Xinqiao Hospital, Chongqing, China. Written informed consent
was obtained from mothers in all cases and the ethics committee of
Xinqiao Hospital approved the study. Heparin was used as the anti-
coagulant. The cord blood volume collected ranged 60–100 ml.
Source of animals and establishment of a hematopoietic
damage model
Fifteen male and fifteen female BALB/c-nu/nu nude mice
(aged 10–12 weeks, 20–25 g body weight) were purchased from
the Third Military Medical University Laboratory Animal Center.
Animals were housed in specific pathogen–free (SFP) rooms of the
Laboratory Animal Center in the Second Affiliated Hospital of
Third Military Medical University. Four
60Co-irradiation groups
(3.5 Gy, 5 Gy, 6.5 Gy, and 8 Gy) were established to simulate
mild, moderate, and severe damages of hematopoietic function to
produce models for HIM damage. The animal experiments were
also approved by the ethics committee of Xinqiao Hospital. The
permit number is No. 20090205.
Culture of HUCBSCs [12]
The mononuclear cells from human cord blood were obtained
by Ficoll density gradient fractionation columns (densi-
ty=1.077 g/l Pharmacia Biotech, Uppsala, Sweden). CD34
+ cells
were separated using the magnetic cell sorting (MACS) system
(Miltenyi Biotec; Bergisch Gladbach, Germany) according to the
manufacturer’s instructions, and percent purity of the positive
fraction was determined using anti-CD34 fluorescein isothiocya-
nate (FITC) and phycoerythrin (PE) conjugate-tagged antibody
(Santa Cruz, CA, USA) by flow cytometer (Becton Dickinson,
Franklin Lakes, NJ, USA). CD34
+ cells were resuspended in
DMEM medium (Gibco, USA) containing 12.5% (v/v) fetal
bovine serum (Hyclone, USA), 12.5% (v/v) horse serum (Gibco,
USA), 10
26 M hydrocortisone, 10 ng/ml SCF (Sigma, USA), and
1 ng/ml bFGF (Sigma, USA). Culture was replaced by fresh
medium after 48 h, and then, it was demi-depopulated weekly and
fresh medium was added to it. After the density of cells had risen
above 80% confluence, HUCBSCs were subcultured with 1:1
ratio under the same culture medium and condition.
Plasmid construction, transfection, and identification [19]
Using recombinant DNA technology, the target gene, VCAM-1,
was cloned into a shuttleplasmidcontaining anEGFPreportergene.
Homologous recombination was performed between the recombi-
nant plasmid and adenovirus genome in BJ5183 cells to produce
recombinant adenoviruses. The recombinant adenovirus-expressing
plasmid was then transfected into 293 cells mediated by liposomes to
allow the packaging and replication of adenoviruses. The transfected
293 cells were observed under a fluorescence microscope, and the
culture supernatant was used to detect the expression of target
protein using western blot analysis. The VCAM-1 gene was then
introduced into HUCBSCs using a highly efficient delivery system,
and the expression of VCAM-1 was detected. Supernatant was then
discarded, and cells were washed twice with culture medium.
Observation of the effect of HUCBSCs on the in vitro
proliferation of cord blood CD34
+ cells
Human cord blood CD34
+ cells were diluted in Iscove’s
Modified Dulbecco’s Medium (IMDM) containing 12.5% (v/v)
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26 mol/L hydrocor-
tisone at 2610
5 cells/ml in culture flasks containing a monolayer
of HUCBSCs. The control group was cord blood CD34
+ cells
without expanded HUCBSCs. Cells were cultured at 37uCi na
5% CO2 incubator for 5 d. The culture medium of each flask was
transferred to a 10-ml centrifuge tube, and some culture medium
was added into the culture flask. After adherent cells were scraped
with a cell scraper, cells were completely dispersed and transferred
into a new culture flask. After attaching for 1 h, non-adherent cells
and floating cells in supernatant were collected and centrifuged at
2506g for 10 min. Supernatant was then discarded, and cells were
washed twice with culture medium. After re-suspension, cells were
counted. Semi-solid cultures of granulocyte/monocyte colony-
forming units (CFU-GM), erythroid burst-forming units (BFU-E),
and megakaryocyte CFUs (CFU-Meg) were established according
to the published literature [20].
Transplantation of VCAM-1 gene–modified HUCBSCs in a
hematopoietic damage model
HUCBSCs were injected through nude mouse tail veins. The
mice were divided into four groups. The control group was infused
with normal saline, the HUCBSC group with 1610
5 HUCBSCs,
the VCAM-1HUCBSC1 group with 1610
5 VCAM-1–modified
HUCBSCs, and the VCAM-1HUCBSC2 group with 1610
6
VCAM-1–modified HUCBSCs. After injection, these experimen-
tal nude mice were housed in SFP animal rooms in Xinqiao
Hospital.
Detection of VCAM-1 in nude mouse bone marrow
stromal cells
Immunocytochemical detection of VCAM-1 in nude
mouse bone marrow stromal cells. Bone marrow stromal
cells from nude mice before transplantation and on days +1, +7,
+14, and +21 were cultured on cover slips for 7 d. Cells were then
washed twice with 0.01 mol/L PBS (pH 7.4), fixed in acetone for
5–10 min, and incubated in 100 ul of peroxidase-blocking solution
for 10 min at 37uC. After washing with PBS three times for 3 min
each, cells were incubated with 100 ul of non-immunized animal
serum at 37uC for 10 min. Cells were washed three times with
PBS (5 min per wash), PBS was discarded, and cells were
incubated with rabbit anti-human VCAM-1 monoclonal
antibody at 37uC for 60 min. After washing with PBS five times
for 3 min each, cells were incubated with 100 ul of biotin-labeled
secondary antibodies at 37uC for 10 min. Cells were washed with
PBS three times for 3 min each and incubated with 100 ul of
streptomycin avidin peroxidase at 37uC for 10 min. After three
more washes with PBS for 3 min each, cells were incubated with
200 ul of DAB solution, then observed under a microscope for 3–
10 min until color developed. After washing with tap water for
5 min, cells were stained with hematoxylin solution for 2 min and
washed again with tap water, acid-alcohol solution rapidly, tap
water, ammonia-water solution, and tap water. Cells were then
dehydrated successively with 70% alcohol once, 95% alcohol
once, and anhydrous alcohol three times for 1 min each. Finally,
cells were cleared with xylene solution, mounted using Permount,
and observed under a microscope.
Flow cytometry of VCAM-1 in nude mouse bone marrow
stromal cells [21]
After the culture medium was discarded, cells were washed with
RPMI1640 twice and digested with 0.25% trypsin containing
0.02% ethylenediaminetetraacetic acid at 37uC for 10 min or until
space between cells became widened and cells began to become
round. After the trypsin was discarded, cells were dispersed by
gently pipetting in an appropriate amount of RPMI and
centrifuged at 1,000 rpm for 10 min. The supernatant was then
discarded, and cells were re-suspended in 4uC PBS at 1610
6 cells/
ml; the survival rate of cells was over 95%. The primary antibody
(VCAM-1) was added into 1 ml of cell suspension at the final
concentration of 20 g/ml and incubated at 4uC for 30 min. PBS
was added in place of primary antibody in the negative control
group. Cells were washed with buffer twice; after residual liquid
was removed, the cell pellet was dispersed by gently tapping.
Fluorescein isothiocyanate–labeled secondary goat anti-mouse
IgG was then added and incubated at 4uC for 30 min. After two
washes with buffer, cells were mixed with 1 ml of buffer and were
detected using a flow cytometer.
Observation of the effect of transplantation of VCAM-1–
modified HUCBSCs on the reconstruction of the function
of HIM
Changes in the hemogram in nude mice. Twenty
microliters of tail vein blood from each transplantation group
was collected on days +1, +3, +5, +7, +10, +14, and +21 after
transplantation. Each blood sample was mixed with 0.2 ml of
dilution buffer and was measured using a blood counter.
Changes in the myelogram. One nude mouse from each
transplantation group on days +1, +7, +14, and +21 was sacrificed
using neck dislocation for myelographic examination.
Bone marrow stromal CFU-F detection [22]
One nude mouse from each group on days +7, +14, and +21
was sacrificed using neck dislocation. After soaking in 75% alcohol
for 5 min, bilateral femoral and tibial bones were peeled off using
rongeurs and smooth forceps and placed in IMDM containing
10% newborn bovine serum (NBS). Bone marrow was washed out
using a 1-ml syringe with a 7-gauge needle; next, 7-, 5-, and 4-
gauge needles were used sequentially to filter single cells from bone
marrow, and 7-, 5-, and 4-gauge needles were used sequentially to
filter cells into single-cell suspensions. Cells were then inoculated
onto IMDM containing 10% NBS, 10% HS, 10
26 mol/L
hydrocortisone, and 100 U/ml penicillin and streptomycin at
1610
6 cells/cm
2. Cells were incubated at 37uC in a 5% CO2
incubator. After 48 h, the supernatant was discarded; half of the
medium was changed every week, and each sample was cultured
in five flasks.
Semi-solid culture of bone marrow mononuclear cells,
CFU-GM, BFU-E, and CFU-Meg from nude mice [23]
One nude mouse from each group on days +7, +14, and +21
was sacrificed using neck dislocation. Mononuclear cells from
bilateral femoral bones were cultured in vitro for CFU-GM, BFU-
E, and CFU-Meg. Each flask had 2610
5 mononuclear cells added
to it.
Dynamic observation of bone marrow pathological slices
after HUCBSC transplantation
Preparation of bone marrow pathological slices:
One nude mouse from day +21 was sacrificed by neck
dislocation, and bilateral tibial bones were removed to make bone
marrow pathological slices. Samples were placed in Bouin fixative
solution (picric acid fixative) for 30–60 min and dehydrated in
69%, 70%, 80%, 95%, and 100% (twice) alcohol. Samples were
embedded in Hemapun865 plastic embedding medium. Hema-
pun865 solution A was first added, followed by an incubation in a
refrigerator for 1–2 h. Then, several drops of solution B was added
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immediately with solutions A, followed by an incubation at room
temperature for 20 min until the solutions had self-polymerized.
After embedding, samples were cut into blocks, sectioned, stained
with HGF, and examined under a microscope.
Preparation of bone marrow pathological slices suitable for
immunofluorescence microscopy:
The high heat generated during preparation of general bone
marrow pathological slices would denature proteins, damage
tissues and cells, and destroy the activities of many enzymes and
antigenicity. To observe whether HUCBSCs were really trans-
planted into living tissues in bone marrow, we used a new
technique to prepare bone marrow pathological slices, the
Hemapun948 cold vacuum embedding technique. The technique
not only can achieve a slow and uniform polymerization but also
can suppress the heat reaction induced by the process of rapid
polymerization, thus preventing heat damage and preserving
many cellular antigenic components. The results indicated that the
cells observed under a light microscope were HUCBSCs homing
back to the bone marrow through veins.
For embedding, bone marrow pathological tissues were fixed in
pre-cooled 4uCBouinfixativesolutionfor1 h,washedwith0.1 ml/L
sodium dimethylarsinate buffer in a 4uC refrigerator for 30 min, and
dehydrated at 4uC in a gradient of alcohol concentrations for 10 min
in each concentration. Living tissue blocks were then placed on the
bottom of a mold with 2 ml of solution A in a type 1354 vacuum
dryer for 2–4 h in a 4uC refrigerator. Two to three drops of alcohol
were then added into the mold with living tissue blocks at 4uCt o
make complete embedding solution; the polymerization was
completed under vacuum conditions.
Statistical analysis
Data were represented as mean values with standard deviation.
Statistical significance was analyzed using the Student’s t test. P
values less than 0.05 were considered significant.
Results
HUCBSC culture
Collection of cord blood and separation and purification
of CD34
+ cells in cord blood. Twenty samples of cord blood
were collected in the study. The average volume was 85628.6 ml,
the number of nucleated cells was 1.8560.72610
7 cells/mL, the
number of mononuclear cells purified using Ficoll was
2.4361.37610
8, the number of CD34
+ cells separated using
magnetic-activated cell sorting was 5.4762.29610
6, and the
purity determined by flow cytometry was 0.9160.04.
Dynamic observation of the growth of HUCBSCs. After
3–4 d of culture in the Dexter culture system, adherent cells could
be observed among the CD34
+ cells from cord blood and were
round, triangular, or irregularly shaped (Fig. 1-A). After 9–14 d
(average 11.2 d), stromal cell colonies began to appear (Fig. 1-B).
The number of colonies reached its maximum after 15–22 d
(average 19.6 d) (Fig. 1-C). With increasing culture time, cell
Figure 1. Dynamic observation of the growth of Dexter-cultured HUCBSCs. 1-A: Dexter-cultured HUCBSCs formed adherent cells on day 3.
1-B: Dexter-cultured HUCBSCs formed smaller stromal cell colonies on day 14. 1-C: There were larger and more stromal cell colonies in Dexter-
cultured HUCBSCs on day 21. 1-D: Stromal cells became confluent in Dexter-cultured HUCBSCs on day 28. (inverted microscope, 6100). 1-E:
Fibroblast-like (thick arrow) and ‘‘small-round’’ cells (thin), (Wright’s staining, inverted microscope61000). 1-F: Macrophage-like cells, (inverted
microscope 61000).
doi:10.1371/journal.pone.0031741.g001
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morphologies such as round, oval, or spindle shapes. Cell types
were mainly fibroblast-like or macrophage-like. After 28 d of
culture, adherent cells became confluent (Fig. 1-D). The major
presentations of morphology features of HUCBSCs were as
follows: a. Fibroblast-like cells, which accounted for 56.5%; the
cells were spindle-shaped with abundant cytoplasm that was
purple in color, thicker chromatin, and a non-obvious nucleolus
(Fig. 1-E, thick arrow). b. Macrophage-like cells, which accounted
for 38%; the cells were round and bigger, processes on cell
membrane were chimeric, the cytoplasm was abundant, the
chromatin was thick, and the nucleolus was obvious (Fig. 1-F). c.
‘‘Small-round’’ cells, which accounted for 5.5%; the cells were
smaller and looked like lymphocytes, the cytoplasm was blue, the
chromatin was thin, and the nucleolus was obvious (Fig. 1-E, thin
arrow).
Transfection of the Ad-VCAM-1-EGFP adenovirus vector
into HUCBSCs. The percentage of live HUCBSCs after
VCAM-1 transfection was 94%; the percentage of live cells in
the control cells not transfected with VCAM-1 was 97%. The
stained HUCBSCs before and after transfection are shown in
Fig. 2-A and 2-B. Semi-quantitative RT-PCR showed that the
expression of VCAM-1 mRNA significantly increased after
transfection (Fig. 2-C). Immunocytochemistry showed that the
positive rate of VCAM-1 protein expression significantly increased
after transfection (Fig. 2-D, E). The percentage of green
fluorescent cells was counted under a fluorescence microscope
(Fig. 2-F). The efficiency of liposome-mediated transfection of
recombinant plasmids in this study was 40–70%, with an average
of 54.6%.
The effect of HUCBSCs on the in vitro proliferation of
cord blood CD34
+ cells. On days 1–3, myeloid/mononuclear,
erythroid, and megakaryocytic cell lineages grew as single cells;
they began to proliferate after day 4. At first, there were cell
clusters of 3–5 cells; colonies could be observed after day 7, and
colonies significantly increased during days 10–12. CFU-GM were
colorless cell masses with more than 50 cells; cells were tightly
connected and showed dense colonies (Fig. 3-A). BFU-E were
erythroid progenitor cell clusters with more than 50 cells that were
hemoglobinized; cells in each colony were round with small
volume and were tightly connected, and because hemoglobin was
synthesized in the cytoplasm, colonies were dark red (Fig. 3-B).
CFU-Meg were cell masses with more than 20 cells; these cells
were larger in size, with irregular shapes (Fig. 3-C). After 14 days,
colonies gradually decreased in size, and cells degenerated. The
number of colonies of each lineage in groups supported by
HUCBSCs was higher than that in each control group without
HUCBSC feeder layers (p,0.01), while the number of colonies of
each lineage in the VCAM-1–modified HUCBSC group was
higher than that in the HUCBSC-supported group and control
group without a HUCBSC feeder layer (p,0.01) (Fig. 3-D).
Establishment of a nude mouse model for HIM
damage. Dynamic changes of the nude mouse hemogram
after 3.5 Gy, 5 Gy, 6.5 Gy, and8 Gy irradiation
The changes in the hemogram differed among the nude mice
that received the four different doses of irradiation. In the 3.5 Gy
group, the white blood cell (WBC) and platelet (PLT) counts were
the lowest on day +3, and the red blood cell (RBC) count was the
lowest on day +5; after that, indicators of hemogram rapidly
recovered. The WBC and PLT counts of the 3.5 Gy, 5 Gy, and
6.5 Gy groups were the lowest on day +5, and the RBC counts of
the 5 Gy and 6.5 Gy groups were the lowest on day +7. The
recovery in the 5 Gy group was faster than that in the 6.5 Gy
group. One out of three nude mice died in the 6.5 Gy group.
When the radiation dose increased to 8 Gy, the hematopoietic
function of nude mice could not be recovered, which led to the
death of nude mice, and experiments could not be continued
(Fig. 4-A–E).
Figure 2. HUCBSCs transfected with the Ad-VCAM-1-EGFP adenovirus plasmid. 2-A: HUCBSCs before VCAM-1 transfection. 2-B: HUCBSCs
after VCAM-1 transfection. 2-C: Detection of VCAM-1 expression before and after transfection using RT-PCR, M: DNA marker; 1,2,3: before transfection;
3,4,5: after transfection. 2-D: The weak expression of VACM-1 in HUCBSCs before transfection. 2-E: The increased expression of VCAM-1 in HUCBSCs
after transfection. 2-F: Immunofluorescence detection of VCAM-1 of HUCBSCs after transfection.
doi:10.1371/journal.pone.0031741.g002
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from nude mice after 3.5 Gy, 5 Gy, 6.5 Gy, and 8 Gy
irradiation. We focused on trabecular bone tissues because
the morphology of stromal cells and hematopoietic precursor cells
and their locations could be observed in these tissues. With
increased radiation dose, characteristic changes in the bone
marrow pathological slices, especially in tissues around trabecular
bone tissues, were apparent: cell bodies of bone marrow stromal
cells close to trabecular bone became larger, with loose and
disordered arrangement; the number of scattered hematopoietic
progenitor cells decreased; and, the number of cells with ring-
shaped nuclei increased in bone marrow. These phenomena were
most obvious in the 6.5 Gy and 8 Gy groups (Fig. 4-F and G).
Overall, the results after the four different doses of irradiation
showed that after 8 Gy irradiation, nude mice died because
hematopoietic function could not be recovered in time, leading to
the termination of experiments. The hematopoietic function of
nude mice in the 3.5 Gy, 5 Gy, and 6.5 Gy groups basically could
be recovered, although longer time was needed; most mice housed
in SPFanimalrooms survived independently. Bone marrow stromal
CFU-F detection showed that the function of bone marrow stromal
cells from nude mice in the 5 Gy and 6.5 Gy groups had significant
damage; therefore, irradiated animals could be used as a model for
HIM damage. To better observe the effects of HUCBSC
transplantation on the improvement of HIM function and repair
ofhematopoieticdamage whileexcludingtheeffectofHSCinfusion
on the experiments, we chose 6.5 Gy in the subsequent studies for
the radiation dose in the nude mouse model for HIM damage.
Furthermore, in vitro–expanded HUCBSCs were infused to observe
their effect on the repair of HIM function in nude mice and the
recovery of hematopoietic damage.
The expression of VCAM-1 in nude mouse stromal cells at
different time points after HUCBSC transplantation. Immun-
ocytochemistry showed that the expression of VCAM-1 in in vitro–
cultured nude mouse stromal cells on days +14, and +21 after
transplantation decreased in the control and HUCBSC
transplantation groups; the expression still had not recovered on
day +21 (Fig. 5-A, B, C, D). The expression of VCAM-1 in nude
mouse bone marrow stromal cells in the VCAM-1-HUCBSC-1 and
VCAM-1-HUCBSC-2 groups on day +14 was significantly higher
than that in the control and HUCBSC transplantation groups
(Fig.5-EandF). Withanincreased numberoftransplanted cellsand
transplantation time, the expression of VCAM-1 showed an
increasing trend, with the expression of VCAM-1 highest in the
VCAM-1-HUCBSC-2 group (Fig. 5-G and H). Flow cytometric
results also confirmed the above trends (Fig. 5-I).
Effects of VCAM-1 gene–modified HUCBSCs on the repair
of hematopoietic function. Changes in peripheral WBC and
Figure 3. The effect of HUCBSCs on the in vitro proliferation of cord blood CD34
+ cells. 3-A: Culture of CFU-GM from human cord blood
CD34
+ cells. 3-B: Culture of BFU-E from human cord blood CD34
+ cells. 3-C: Culture of CFU-Meg from human cord blood CD34
+ cells. 3-D: Comparison
of numbers of colonies in the three groups. * compared with control group, P,0.01; ** compared with control and HUCBSCs groups, p,0.01.
doi:10.1371/journal.pone.0031741.g003
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mice in each group rapidly decreased 1 d after transplantation,
reached the lowest level on day +5, and then gradually increased.
On day +21, the WBC levels in the HUCBSC group and VCAM-
1-HUCBSC-1 group recovered to the day +1 level. On day +14,
the WBC level of nude mice in the VCAM-1-HUCBSC-2 group
returned to the day +1 level. On day +21, the WBC level was
significantly higher than that in the other three groups. On day
+21, the WBC count in the control group had not returned to the
day +1 level (Fig. 6-A).
The PLT counts in each group rapidly decreased on day +1
after transplantation. The PLT counts of the control group and
HUCBSC group reached the lowest levels on day +7 and then
gradually increased; on day +21, the PLT levels still had not
returned to the day +1 level. The PLT counts of the VCAM-1-
HUCBSC-1 and VCAM-1-HUCBSC-2 groups reached the
lowest levels on day +5, while the PLT counts on day +21 were
higher than that on day +1. The VCAM-1HUCBSC2 group had
the highest recovery level (Fig. 6-B).
Dynamic changes in the myelogram of nude mice after
HUCBSC transplantation using 6.5 Gy irradiation. Bone
marrow proliferated more actively in mouse than in healthy
human. Because the number of cells is excessively large under the
low-powered microscope and therefore is difficult to count, we
compared the difference of bone marrow hyperplasia among four
groups by counting nucleated cells in each oil immersion lens field.
Bone marrow hyperplasia in control nude mice on day +1 after
irradiation was basically normal (Fig. 7-A). Bone marrow
hyperplasia significantly decreased on day +7 and day +14, and
the number of nucleated cells was lowest in day +14(Fig. 7-B). The
level of hyperplasia had not fully recovered to normal on day +21
(Fig. 7-C). Bone marrow hyperplasia in the HUCBSC
transplantation group started to decrease on day +7, reached its
lowest level on day +14 (Fig. 7-D), and recovered to the normal
level on day +21 (Fig. 7-E). The bone marrow hyperplasia in the
VCAM-1HUCBSC1 group was already recovered on day +14
(Fig. 7-F), while the bone marrow hyperplasia in the VCAM-1-
HUCBSC-2 group only had slightly decreased on day +7 (Fig. 7-
G) and recovered to the normal level by day +14 (Fig. 7-H). Bone
marrow morphological visualization of the control group and
VCAM-1-HUCBSC-2 group on day +14 and day +21 showed a
significant difference in the numbers of nucleated cells in bone
marrow in these two groups. The bone marrow hyperplasia in the
HUCBSC transplantation group was also significantly higher than
that in the control group on day +21 (Fig. 7-I).
6.3 The effects of nude mouse bone marrow stromal cells on
CFU-F, myeloid, erythroid, and megakaryocytic lineage cells after
transplantation of HUCBSCs
Figure 8 shows that after HUCBSC transplantation, the
numbers of CFU-F, CFU-GM, BFU-E and CFU-Meg were the
lowest on day +7 after transplantation and then gradually
increased. At any time point, the numbers in the transplantation
group were always higher than those in the control group; the
numbers in the VCAM-1-HUCBSC-2 group were significantly
higher than those in the HUCBSC group and VCAM-1-
HUCBSC-1 group (Fig. 8).
Dynamic observation of bone marrow pathological slices
after HUCBSC transplantation. Observation using a light
microscope. Compared to the control group on day +21, adherent
bone marrow stromal cells that were neatly arranged in parallel
could be observed around trabecular bone tissues in bone marrow
pathological slices from the HUCBSC and VCAM-1-HUCBSC
groups. There were large amounts of nucleated cells close to
stromal cells around trabecular bone, which were mainly
proliferating progenitor cells, indicating that the hematopoietic
function of bone marrow was very strong. This phenomenon was
most prominent in the VCAM-1-HUCBSC groups and was most
significant in the group with more infused cells (Fig. 9).
Figure 4. Dynamic observation of the nude mouse hemogram, bone marrow stromal CFU-F count, and bone marrow pathological
slices after different doses of irradiation. 4-A: WBC counts. 4-B: RBC counts. 4-C: Hemoglobin counts. 4-D: PLT counts. 4-E: CFU-F counts in bone
marrow stromal cells, * compared with control, 3.5 and 5 Gy groups, P,0.01. 4-F: Nude mouse bone marrow pathological slices after 6.5 Gy
irradiation. 4-G: Nude mouse bone marrow pathological slices after 8 Gy irradiation.
doi:10.1371/journal.pone.0031741.g004
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scence was not observed in pathological slices from the control
group or HUCBSC group at any time point. Green fluorescence
was observed in the bone marrow pathological slices of the
VCAM-1HUCBSC groups on days +7, +14, and +21 after
transplantation. With increasing time, the intensity and density of
fluorescence gradually decreased, reaching their minimum levels
on day +21 after transplantation. At the same time point, the
Figure 5. Expression of bone marrow stromal cell VCAM-1 in nude mice after HUCBSCs transplantation. 5-A: control group +14 d; 5-B:
control group +21 d; 5-C: HUCBSCs group +14 d; 5-D: HUCBSCs group +21 d; 5-E: VCAM-1-HUCBSCs-1 group +14 d; 5-F: VCAM-1-HUCBSCs-1 group
+21 d; 5-G: VCAM-1-HUCBSCs-2 group +14 d; 5-H: VCAM-1-HUCBSCs-2 group +21 d (immunohistochemistry under inverted microscope6400); 5-I:
flow cytometry for the expression of VCAM-1, * compared with control group, P,0.05, * *compared with control group, P,0.01,
D compared with
HUCBSCs group P,0.05.
doi:10.1371/journal.pone.0031741.g005
Figure 6. Dynamic changes in peripheral WBC and PLT counts in nude mice after transplantation. 6-A: Dynamic changes in WBC counts
after transplantation. 6-B: Dynamic changes in PLT counts after transplantation.
doi:10.1371/journal.pone.0031741.g006
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HUCBSC-2 group were significantly higher than those in the
VCAM-1-HUBCSC-1 group (Fig. 10).
Discussion
In our previous study, we had successfully cultured and isolated
HUCBSCs and demonstrated that they could secret hemopoietic
growth factors such as GM-CSF, TPO, and SCF, which provided
a new hematopoietic resource [12]. In the current experiment, we
initially established a co-culture system for HUCBSCs and
umbilical cord blood CD34
+ cells. The results of co-culture of
HUCBSCs and cord blood CD34
+ cells in this study showed that
when using HUCBSCs as the adherent layer, the formation of
colonies of each hematopoietic lineage significantly increased;
erythroid, myeloid, and megakaryocytic lineages all formed more
colonies than those in the control groups without HUCBSCs as
feeder layers 12 d after co-culture. One possible cause of these
results is that HUCBSCs secrete cytokines that directly contact the
hematopoietic cells and regulate their growth. However, these
results confirm that HUCBSCs can support the formation of the
HIM. The exact mechanism of the interaction between the HIM
formed by stromal cells and hematopoietic parenchymal cells is
still unclear; the current consensus is that it is due to the direct
contact between stromal cells in the HIM and HSCs or the
important function of secreted cytokines in the regulation of
hematopoiesis. However, the specific forms and the mechanisms of
the resultant signal transduction pathways have not been
elucidated. Yanai [24] found that when HSCs and bone marrow
stromal cells were co-cultured, HSCs had a tendency of migrating
toward stromal cells, while more mature hematopoietic cells would
only move to the surface or float in culture medium. Similar results
have also been observed in studies using cell lines. When the HSC
line THS119 was inoculated onto stromal cell layers, THS119
cells attached to the surface of stromal cells and migrated to the
cobblestone-like colony-forming region of the stromal cell layers
before proliferation. Wagner also found that hematopoietic cells
formed large amounts of processes that connected to stromal cells
at multiple points, and some processes reached the inner layer of
stromal cells. When stromal cells took up dyes, the dyes entered
the adjacent hematopoietic cells and stromal cells, indicating that
the direct contact between stromal cells and hematopoietic cells
Figure 7. Dynamic changes in the myelogram in nude mice after HUCBSCs transplantation after 6.5 Gy irradiation. 7-A: The degree of
bone marrow hyperplasia in control nude mice on day +1 after transplantation. 7-B: Myelogram of control nude mice on day +14. 7-C: Myelogram of
control nude mice on day +21. 7-D: Myelogram of nude mice in the HUCBSC group on day +14. 7-E: Myelogram of nude mice in the HUCBSC group
on day +21. 7-F: Myelogram of nude mice in the VCAM-1-HUCBSC-1 group on day +14. 7-G: Myelogram of nude mice in the VCAM-1-HUCBSC-2 group
on day +7. 7-H: Myelogram of nude mice in the VCAM-1-HUCBSC-1 group on day +21. 7-I: Counting of bone marrow nucleated cells in nude mice
after HUCBSCs transplantation, * compared with control group, P,0.01;
D compared with HUCBSCs group P,0.05;
DD compared with HUCBSCs
group, P,0.01.
doi:10.1371/journal.pone.0031741.g007
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molecules. The contact was achieved through the adhesion
molecules on the surface of stromal cells and hematopoietic cells.
CAMs are the molecular bases of homing and information
transfer in HSCs/HPCs [25]. The adhesion of stem cells and
stromal cells is important for hematopoietic growth and develop-
ment. For the functions of hematopoietic stromal cells, the
expression of important CAMs, such as CD106 (VCAM-1),
CD29 (integrin), and CD44, is helpful for stromal cells to exert
their hematopoietic regulation functions [26,27,28]. CAMs can
promote the homing of stromal cells after transplantation and play
important roles in lymphocyte aggregation and immune response
Figure 8. Effects of nude mouse bone marrow stromal cells on CFU-F, myeloid, erythroid, and megakaryocytic lineage cells after
transplantation of HUCBSCs. 8-A: changes of CFU-F in nude mice at different time points after HUCBSCs transplantation. 8-B: changes of CFU-GM
in nude mice at different time points after HUCBSCs transplantation. 8-C: changes of BFU-E in nude mice at different time points after HUCBSCs
transplantation. 8-D: changes of CFU-Meg in nude mice at different time points after HUCBSCs transplantation.. * compared with control group,
P,0.05;** compared with control group, P,0.01;
D compared with HUCBSCs group P,0.05;
DD compared with HUCBSCs group, P,0.01;
q ccompared with VCAM-1-HUCBSCs-1 group P,0.05;
qqcompared with VCAM-1-HUCBSCs-1 group P,0.01.
doi:10.1371/journal.pone.0031741.g008
Figure 9. Observation of the pathological slides of nude mouse bone marrow under light microscope on day +21 after
transplantation. 9-A: control group; 9-B: HUCBSCs group; 9-C: VCAM-1-HUCBSCs-1 group; 9-D: VCAM-1-HUCBSCs-2 group, (HGF staining, inverted
microscope, 6100). Red arrows represent new fibroblast-like cells.
doi:10.1371/journal.pone.0031741.g009
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are not only components of intercellular substances but are also
important components of the ECM produced by stromal cells such
as fibroblasts, endothelial cells, and macrophages. More impor-
tantly, they provide material bases for transmitting information
between cells [11]. Our previous studies confirmed that in vitro–
cultured HUCBSCs express CAMs such as CD29 and CD44 and
secrete ECM components such as Fn, Ln, and type IV collagen,
suggesting that HUCBSCs have the material bases of hematopoi-
etic functional regulation. The expression of VCAM-1 in these
cells was weaker, and VCAM-1 plays important roles in regulating
hematopoiesis in stromal cells and is upstream of CAM activity
(such as CD29) [12], therefore, Ad-VCAM-1-EGFP adenovirus
plasmid–transfected HUCBSCs were established in this study to
observe the hematopoietic supporting functions of HUCBSCs with
increased VCAM-1 expression. Compared with other cultures,
VCAM-1–modified HUCBSC adherent cell layers significantly
increased the number of colonies formed by CD34
+ cells; the
numbers of erythroid, myeloid, and megakaryocytic progenitor
cell colonies formed after 12 d of co-culture were all significantly
higher than in the group with HUCBSC adherent cells layers and
in the control group without HUCBSC adherent layers. These
results indicate that increased expression of VCAM-1 in
HUCBSCs can increase the specific interaction between
VCAM-1 and its receptor a4b1 integrin, increase the adhesion
of HSCs/HPCs, and localize HSCs/HPCs in the HIM.
Therefore, HSCs/HPCs and stromal cells develop a closer
association, which is conducive to the regulation of HSC/HPC
proliferation and differentiation by signal transduction and
secretion of hematopoietic growth factors and ECM components,
thus leading to improved hematopoietic supporting function.
To observe the effect of HUCBSC transplantation on the
recovery of HIM function, which promotes the repair of
hematopoietic damage, we explored different doses of radiation
on the damage of mouse HIM to establish an animal model using
an appropriate dose of radiation to damage the HIM. Hemato-
poietic tissues are sensitive to radiotherapy; studies on hemato-
poietic damage usually use
60Co c-irradiated mice to establish an
animal model for damaged hematopoietic function. However, few
studies have reported on the appropriate radiation dose for
damaging the HIM. We first set up four radiation groups, 3.5, 5,
6.5, and 8 Gy, and observed the changes in nude mouse
hemogram and the formation of bone marrow CFU-F at different
time points after irradiation. The expression of VCAM-1 in nude
mouse bone marrow stromal cells after irradiation was also
detected using flow cytometry. Changes in hemogram were
different after different doses of irradiation. The WBC and PLT
counts of nude mice in the 3.5 Gy group were the lowest on day
+3, and RBC count was the lowest on day +5; the indictors of the
hemogram were then rapidly recovered. The WBC and PLT
counts of nude mice in the 3.5, 5, and 6.5 Gy groups were the
lowest on day +5, and RBC counts in the 5 and 6.5 Gy groups
were the lowest on day +7. The recovery rate of the 5 Gy group
was faster than that of the 6.5 Gy group, and one out of three
nude mice died in the 6.5 Gy group. When the dose increased to
8.0 Gy, the hematopoietic function of nude mice had not
recovered even on day +21; all mice died, and experiments could
not be continued.
When the radiation dose was 8 Gy and there was no support
from HSC transplantation, the nude mice died because hemato-
poietic dysfunction could not be repaired, so experiments could
not be continued. The hematopoietic function of nude mice in the
3.5 Gy, 5 Gy, and 6.5 Gy groups could be self-recovered within
21 d after irradiation, and most nude mice housed in SFP animal
rooms could survive independently; only one nude mouse died,
and experiments could be continued. The bone marrow stromal
CFU-F and VCAM-1 measurement showed that the changes of
CFU-F and VCAM-1 in the 3.5 Gy group were not significant.
The nude mouse bone marrow stromal CFU-F and VCAM-1
were significantly damaged in the 5 Gy and 6.5 Gy groups
compared to those in the control group. The degree of HIM
damage in the 6.5 Gy group was more severe after irradiation.
The number of CFU-F and the expression of VCAM-1 were
significantly different from those in the other two groups;
therefore, the irradiation of nude mice using 6.5 Gy could achieve
the purpose of causing HIM damage and would not cause animal
death, allowing the experiments to continue.
The subsequent in vivo experimental results showed that infusion
of either HUCBSCs alone or VCAM-1–modified HUCBSCs had
significant effects on promoting the recovery of nude mouse WBC
and PLT. The abilities to promote the recovery of hemogram and
bone marrow hematopoietic function, ranging in order from
Figure 10. Observation of the fluorescences in the bone marrow pathological slices of the VCAM-1HUCBSC groups. 10-A: VCAM-1-
HUCBSC-1 group on day +7 after transplantation; 10-B: VCAM-1-HUCBSC-1 group on day +14 after transplantation; 10-C: VCAM-1-HUCBSC-1 group on
day +21 after transplantation; 10-D: VCAM-1-HUCBSC-2 group on day +7 after transplantation; 10-E: VCAM-1-HUCBSC-2 group on day +14 after
transplantation; 10-F: VCAM-1-HUCBSC-2 group on day +21 after transplantation (fluorescence microscope 6100).
doi:10.1371/journal.pone.0031741.g010
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1HUCBSC-1, and HUCBSC group. The control group had a
longer myelogram recovery time, while the recovery time in the
other three groups gradually shortened. The degrees of bone
marrow hyperplasia in the HUCBSC, VCAM-1-HUCBSC-1, and
VCAM-1-HUCBSC-2 groups were the lowest on day +21, day
+14, and day +7, respectively. The CFU-GM, BFU-E, and CFU-
Meg formation abilities in these three groups were stronger than
that in the control group. In particular, when comparing the
VCAM-1-HUCBSC-2 group to the control and HUCBSC
groups, the numbers of nucleated cells, CFU-F, and nude mouse
bone marrow HSCs/HPCs (CFU-GM, BFU-E, and CFU-Meg)
on days 14 and 21 after HUCBSC transplantation were
significantly different, indicating that VCAM-1 modification can
increase the hematopoietic supporting functions of HUCBSCs.
Based on the current study, we believe that the effect of VCAM-
1-modified HUCBSC in reconstructing HIM may be achieved via
the following mechanisms: a) To directly repair the damaged
HIM. The radiation-induced bone-marrow damage can directly
cause the massive destruction of HIM. On day +21, as clearly
shown in the bone marrow pathological slices, a large number of
adherent bone marrow stromal cells were observed around
trabecular bone tissues and the hematopoitic precursor cells
massively proliferated near the stromal cells in the VCAM-1-
HUCBSC groups; on the contrary, only a small number of stromal
cells existed diffusely near the trabecular bone in the control
group. Obviously, HUCBSC transplantation is helpful to repair
the damaged HIM; b) To stimulate hematopoiesis by secreting
hematopoietic growth factors. Our previous study [12] has found
that HUCBSCs can express the mRNAs of hematopoietic growth
factors including GM-CSF, TPO, and SCF. Compared with the
bone marrow stromal cells, HUCBSCs had significantly lower
mRNA expressions of SCF and GM-CSF and higher expression of
TPO, demonstrating that HUCBSCs, similar to bone marrow
stromal cells, are able to secrete and express hemopoietic growth
factors and regulate the hematopoiesis process; and c) the
hematopoiesis-supporting effect mediated by adhesion molecules.
Research has found that the expression of VCAM-1 is relatively
low in HUCBSCs, while VCAM-1 is an important adhesion
molecule for the stromal cells to be involved in hematopoiesis-
regulating. Obviously, this issue may directly affect the normal
functions of HUCBSCs. Therefore, in our study, a VCAM-1 high-
expressing vector was constructed and successfully transfected into
HUCBSCs, and the results indicated that VCAM-1–modified
HUCBSCs had stronger function in repairing HIM and
promoting the recovery of hematopoietic damage.
Overall, these results suggest that VCAM-1–modified
HUCBSCs have a stronger ability to repair HIM function and
promote recovery of hematopoietic functions. These results
demonstrate that VCAM-1 plays an important role in supporting
hematopoiesis in the HIM and that our improvement on the new
type of hematopoietic stromal cells was successful. These results
may help the homing of HUCBSCs to bone marrow after
transplantation and may help HUCBSCs to exert their hemato-
poietic-regulating functions. The above findings are helpful for
investigating the effects of repairing HIM function on the rapid
recovery of hematopoietic damage and its underlying mechanisms,
which may provide a new route for finding more effective ancillary
methods for treating hematopoietic damage.
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